Article Information
History
- November 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maxence Meyer, M.D.1,*,
- Florentin Constancias, Ph.D.2,
- Claudia Worth, MB BChir.3,
- Anita Meyer, M.D.4,
- Marion Muller, M.D.1,
- Alexandre Boussuge, M.D.1,
- Georges Kaltenbach, M.D., Ph.D.1,
- Elise Schmitt, M.D., Ph.D1,
- Saïd Chayer, PhD, HDR.,, Ph.D5,
- Aurélie Velay, PharmD., Ph.D6,7,
- Thomas Vogel, M.D., Ph.D.1,
- Samira Fafi-Kremer, PharmD6,7 and
- Patrick Karcher, M.D.1
- 1Department of Geriatric, University Hospitals of Strasbourg, France
- 2ETH Zürich, Department of Health Sciences and Technology, Zurich, Switzerland
- 3Nuffield Department of Rheumatology, Orthopaedics and Musculosckeletal Sciences, University of Oxford
- 4COVID Vaccination Center, Offenburg, Germany
- 5Department of Clinical Research and Innovations, University Hospitals of Strasbourg, France
- 6Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- 7INSERM, UMR_S1109, LabEx TRANSPLANTEX, Research Center for Immunology and Hematology, Faculty of Medicine, University Hospital Federation (FHU) OMICARE, Federation of Translational Medicine of Strasbourg (FMTS), University of Strasbourg, France
- ↵*Corresponding authors
Maxence Meyer, MD : maxence.meyer{at}chru-strasbourg.fr, 83 rue Himmerich, 67000 STRASBOURG
Posted November 19, 2021.
Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds
